(BRK.A), (BRK.B)
Lubrizol, a Berkshire Hathaway company and global leader in specialty chemicals, has partnered with Polyhose to inaugurate a new medical manufacturing facility in Chennai, Tamil Nadu. The state-of-the-art plant will produce precision extruded medical tubing for minimally invasive medical devices, supporting the rapid growth of India’s medical technology and healthcare sectors.
The ISO 13485-certified facility is designed to deliver high-quality medical tubing backed by stringent quality control and the same manufacturing standards followed across Lubrizol’s global network. The investment strengthens the company’s ability to serve customers in India while also supporting international markets.
The facility will manufacture precision extruded tubing using a range of high-performance materials, including polyamides, nylon, Pebax®, polypropylene, polyethylene, and Lubrizol’s medical-grade thermoplastic polyurethane (TPU).
The new site is expected to enhance India’s domestic capacity for precision medical tubing, supporting the country’s efforts to expand local medical device manufacturing, reduce dependence on imports, and improve access to safe, high-quality healthcare products.
©2026 David Mazor
Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.